Supplier qualification
The risk-based, documented process — typically risk assessment, technical questionnaire, on-site audit (or qualified remote alternative), receipt of three qualifying lots and a written Quality Agreement under EU GMP Chapter 7 — that establishes a supplier is capable of consistently meeting agreed specifications before that supplier appears on the Approved Supplier List and before their material is dispensed or assembled into a regulated product.
01What supplier qualification is
Supplier qualification is the documented decision — by Quality, on behalf of the company — that a supplier of a starting material, intermediate, primary packaging, secondary packaging, equipment, or GxP service is technically and quality-systemically capable of consistently meeting the company's specifications, and may be added to the Approved Supplier List. It is required by EU GMP Chapter 5, ICH Q7 §7, FDA's expectations under 21 CFR 211.84 and 820.50, ISO 13485 §7.4, 21 CFR 111.75 for dietary supplements, and Article 46(f) of Directive 2001/83/EC for finished pharmaceutical manufacturers.
02Risk-tiering — not every supplier needs the same rigour
ICH Q9(R1) Quality Risk Management drives the proportionality. Suppliers are tiered by the impact their material or service could have on product quality, patient safety and regulatory compliance:
| Tier | Examples | Qualification rigour |
|---|---|---|
| Critical | API, drug substance, sterile primary packaging, contract manufacturer, contract sterilisation, CRO | Risk assessment + technical + quality questionnaire + on-site audit + three qualifying lots + Quality Agreement + annual re-audit |
| Major | Excipients (functional), secondary packaging, in-process consumables, calibration providers | Risk assessment + questionnaire + audit (on-site every 3-5 years) + qualifying lots + Quality Agreement |
| Minor | Office supplies, non-product-contact consumables, GMP-irrelevant services | Approved Vendor List entry only — no full qualification |
Mis-tiering — particularly under-tiering a Major as Minor — is the single most common Form-483 supplier-management finding.
03The qualification process (Critical / Major tier)
- Request raised by procurement / development; QA confirms the tier and the qualification plan.
- Risk assessment — supplier history, country, regulatory inspection record (FDA 483s, EU GMP non-compliance, MHRA reports), prior relationship.
- Technical questionnaire — manufacturing process, change-control practices, complaint handling, sub-supplier management, regulatory registrations.
- Quality questionnaire — quality system maturity (ISO 9001 / ICH Q10 / ISO 13485 / 21 CFR Parts), most recent regulatory inspection outcomes, audit and CAPA practices, data-integrity programme.
- On-site audit (or qualified remote / virtual audit for lower-tier or COVID-context cases) — performed by qualified auditor, against an agreed scope, with a written report and a CAPA tracker.
- Three qualifying lots — received, tested against the agreed specification, including identity, purity, key impurities and physical attributes; lot-to-lot consistency assessed.
- Quality Agreement — written, signed by both parties, covering scope, responsibilities, change notification, complaint handling, regulatory liaison, audit rights, retention. EU GMP Chapter 7 makes this mandatory for outsourced GMP activities.
- Approved Supplier List entry — Quality signs the qualification decision; supplier appears on the ASL with the qualified material, the spec, the qualified manufacturing site, and the qualification expiry / next-audit date.
04On-site supplier audit — the workhorse evidence
The on-site audit is typically 1-3 days, covering: facility (production areas, warehouse, QC labs, utilities), quality system (document control, training, CAPA, change control, deviation, complaints), production (process flow, IPC, recipe control, equipment qualification), QC (method validation, OOS handling, stability if applicable), and traceability (lot genealogy from raw to finished). The auditor leaves with a written list of observations; the supplier responds with a CAPA plan; the auditor verifies closure before issuing the final report. EU GMP Annex 16 expects QPs to know the supplier audit is current; FDA expects equivalent due diligence.
Remote / virtual audits — accepted by most regulators since 2020 — are still typically followed by an on-site audit on the next qualified cycle, unless the supplier's risk profile justifies remote-only (e.g. low-risk excipient supplier already audited multiple times).
05The Quality Agreement
EU GMP Chapter 7 §7.10-7.18 (and ICH Q7 §17, and FDA's 2016 Quality Agreement guidance) make the written Quality Agreement mandatory for outsourced GMP activities — contract manufacturing, contract testing, contract sterilisation, packaging, distribution. The agreement is distinct from the commercial supply agreement: it cannot be conflated with it, and it must clearly assign every quality responsibility — change notification with minimum lead time, complaint handling, deviation reporting, regulatory inspection rights, sub-contracting controls, audit rights with reasonable notice, retention of records. A missing or weakly-drafted Quality Agreement is a top Form-483 contractor-related observation.
06Ongoing supplier performance and re-qualification
- Performance scorecard — OTIF (on-time-in-full), CoA-vs-actual delta, complaint rate, deviation rate. Trends below threshold trigger CAPA at the supplier (open a non-conformance with the supplier as part of the company's CAPA system).
- Periodic re-audit — typically every 3 years for Critical, every 5 for Major; risk-based extension possible with strong scorecard evidence.
- Supplier change notification — every change at the supplier (process, equipment, site, sub-supplier) must be notified per the Quality Agreement; the company assesses impact, opens change control if needed, and approves before the change ships.
- Disqualification — sustained poor performance, regulatory action against the supplier, or material change that exceeds the qualified envelope triggers disqualification; alternate suppliers must be in place for single-source critical materials.
07Common Form-483 / EU PIC/S supplier findings
- Supplier on the ASL with no qualification evidence on file (especially after acquisitions).
- Quality Agreement not in place for a contract manufacturer.
- Audit overdue — re-qualification programme not driven by a calendar.
- Supplier change made without notification; manufacturer found out at receipt of an off-spec lot.
- Risk tier set as 'Minor' for an active ingredient or sterile component.
- On-site audit report not closed (open observations from 2 years ago).
- Sub-supplier chain not mapped — e.g. the API supplier's own starting-material supplier is unknown.
- Quality Agreement and commercial supply agreement conflated, signed once 5 years ago, never revisited.
08How V5 Ultimate supports supplier qualification
- Supplier master holds every supplier, the qualified material(s), the qualified site(s), the risk tier, the qualification status, the Quality Agreement reference, the last audit date, the next audit due, and the named contact at the supplier.
- Qualification workflow walks through the documented steps — risk assessment, questionnaires (templated by tier), audit planning + report capture, qualifying-lot test results, Quality Agreement upload, QA sign-off via two-person e-signature.
- Approved Supplier List is the queryable single source of truth — purchase orders for a material must be against a qualified supplier for the qualified site; off-list ordering is hard-blocked unless an emergency override is invoked with a Major deviation.
- Performance scorecard auto-computes OTIF, CoA-vs-actual, complaint rate, deviation rate per supplier per material; trends below threshold open a CAPA with the supplier as the subject and notify procurement.
- Change-notification workflow: the supplier portal (where used) lets the supplier file change notifications directly; impact assessment is routed to the right SME and to QA; an approved change updates the supplier master and any open POs reflect the new envelope.
- Re-audit calendar: every Critical / Major supplier has a calendared next-audit date driven by the qualification cycle; the audit programme cannot fall behind silently.
Frequently asked questions
Q.Do all suppliers need a Quality Agreement?+
No — only suppliers performing GMP-relevant activities (contract manufacturers, testing labs, sterilisers, packagers, distributors) require a formal Quality Agreement per EU GMP Chapter 7 and FDA's 2016 guidance. Material suppliers (API, excipients, primary packaging) require qualification under Chapter 5 and a Technical Specification, but a full Chapter-7-style Quality Agreement is often replaced by a shorter Quality Specification covering change notification and complaint handling.
Q.Are remote audits acceptable?+
Yes for many cases — most regulators accept remote / virtual audits, particularly for low-to-medium risk suppliers and for periodic re-audits where on-site has been done previously. For initial qualification of a Critical supplier most companies and most regulators still expect on-site at least once; for COVID-era exceptions, a follow-up on-site audit on the next cycle is normal.
Q.How many qualifying lots is enough?+
Three is the industry default and aligns with the historical three-batch validation logic. Some companies use 5-10 for highly variable materials (e.g. botanical extracts) or 1-2 for tightly-controlled commodity materials with extensive supplier history. The rationale is documented in the qualification plan and is risk-based.
Q.What about suppliers acquired with a company acquisition?+
All Critical and Major suppliers inherited via M&A must be brought into the acquirer's qualification programme on a defined timeline. The acquirer cannot rely indefinitely on the acquired company's prior qualification — different ASL, different Quality Agreement, often different risk tiering. This is a frequent post-acquisition Form-483 finding when the integration plan slipped.
Q.Does this apply to software and IT vendors?+
Yes for GxP-relevant software and IT services — GAMP 5 + Annex 11 + Part 11 expect the vendor to be qualified, the software validated, and the service-level agreement (often an Annex to the Quality Agreement) to cover change notification, incident handling and data integrity. For non-GxP IT, ordinary procurement vendor management is sufficient.
Primary sources
Further reading
- Supplier scorecardPerformance monitoring after qualification; feeds re-qualification.
- Supplier risk managementICH Q9 risk tier drives qualification rigour + audit frequency.
- Audit managementOn-site supplier audit is the workhorse evidence.
- Change controlA change at the supplier triggers re-qualification.
- EU GDPGDP §5.2 supplier verification for wholesalers.
V5 Ultimate ships with the Supplier qualification controls already wired in — audit trail, e-signatures, validation evidence. Free trial, no credit card, onboard in days, not months.
